Shelya X. Zeng
Tulane University(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, RNA modifications and cancer, Ubiquitin and proteasome pathways, Cancer Research and Treatments, Epigenetics and DNA Methylation
Most-Cited Works
- → Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition(2004)488 cited
- → p53 downregulates Down syndrome‐associated DYRK1A through miR‐1246(2011)143 cited
- → Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding(2017)108 cited
- → A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53(2012)107 cited
- → AMP-Activated Protein Kinase Induces p53 by Phosphorylating MDMX and Inhibiting Its Activity(2013)105 cited
- → SSRP1 functions as a co-activator of the transcriptional activator p63(2002)92 cited
- → Ribosomopathies: Mechanisms of Disease(2014)89 cited
- → MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation(2002)87 cited
- → Targeting p53-MDM2-MDMX Loop for Cancer Therapy(2014)85 cited
- → Reviving the guardian of the genome: Small molecule activators of p53(2017)77 cited